SELLAS Life Sciences Group, Inc. (SLS)

2.245 +0.20 (+10.05%) USD  |  NASDAQ  |  Dec 16, 15:00
More

SELLAS Life Sciences Group Research and Development Expense (Annual): 19.10M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Geron Corp. 103.74M
GT Biopharma, Inc. 5.798M
ADMA Biologics, Inc. 1.813M
NovaBay Pharmaceuticals, Inc. 0.042M
Palatin Technologies, Inc. 14.90M